GovChime
Notice ID: 88bfddd9918141ee93a2b26dfdc11537Combined Synopsis/Solicitation

CDRH-2024-122027-Leakage Testing in Microfluidic Devices

Archived on June 9, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
May 3, 2024
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Place of performance
Silver Spring, MD, 20993
Last updated
Dec 4, 2025

Identifiers

Solicitation number
FDA-RFQ-CDRH-2024-122027
Notice ID
88bfddd9918141ee93a2b26dfdc11537

Description

FDA needs a leakage testing system that will be used for accurate detection of leaks in microfluidic devices under different operating conditions (i.e., flow rates and pressures) to understand the performance of existing testing platforms for assessing emerging device technologies. This system will benefit FDA regulatory science research and significantly reduce the test method development time by removing the need for FDA to design, develop, build, test, and validate a custom solution. See attached.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:FDA-RFQ-CDRH-2024-122027
  1. Combined Synopsis
  1. Combined SynopsisCurrentMay 3, 2024

    CDRH-2024-122027-Leakage Testing in Microfluidic Devices

    Notice 88bfddd9918141ee93a2b26dfdc11537 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDA-RFQ-CDRH-2024-122027

Archive Date

Jun 9, 2024

Office Address

Beltsville, MD, 20705